Clinical Trials Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Trial Research
Molecular Insight Pharmaceuticals, Inc. Announces Second Quarter 2007 Financial Results
August 27th, 2007
Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced financial results for the quarter ended June 30, 2007 and provided financial and operational guidance for fiscal year 2007. "Molecular Insight has had a very productive second quarter in progressing our robust portfolio of promising and innovative molecular imaging pharmaceuticals and targeted radiotherapeutics for cancer," said David S. Barlow, Chairman and CEO of Molecular Insight. "Our clinical development programs are all on or ahead of plan. We have initiated the planned pivotal registration trial for Zemiva and are actively enrolling patients on schedule. Our Phase 1 of a planned Phase 1/2 trial for...
Source: Clinical Trials Week (2007-08-27)
|
